Microtubule affinity-regulating kinases (MARKs) have become a topic of interest in AD due to their high affinity for tau, their ability to alter tau aggregation, and their potent regulation of tau-MT binding (33, 34, 35). Here, MAPT is linked to Alzheimer disease.